Evidence map›Paper›PMID 30116333›Full record

ArticleExperimental and therapeutic medicine2018

LAP

Xi Ou, Jing Guan, Jing-Sen Chen, Jie-Cao Ying, Xiao-Ping Liu, Pei-Kai Tian, Ji-Kui Liu, Li-Ping Nie, Yang Zhao, Guang-Yin Yu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma.Cellular and molecular gastroenterology and hepatology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xi OuDepartment of Hepatobiliary and Laparoscopic Surgery, Shenzhen Hospital, Peking University, Shenzhen, Guangdong 518036, P.R. China.
Jing GuanDepartment of Obstetrics and Gynecology, Xiamen University Affiliated Zhongshan Hospital, Xiamen, Fujian 361004, P.R. China.
Jing-Sen ChenDepartment of Hepatobiliary and Laparoscopic Surgery, Shenzhen Hospital, Peking University, Shenzhen, Guangdong 518036, P.R. China.
Jie-Cao YingDepartment of General Surgery, Jinhua People's Hospital, Jinhua, Zhejiang 321000, P.R. China.
Xiao-Ping LiuDepartment of Hepatobiliary and Laparoscopic Surgery, Shenzhen Hospital, Peking University, Shenzhen, Guangdong 518036, P.R. China.
Pei-Kai TianDepartment of Hepatobiliary and Laparoscopic Surgery, Shenzhen Hospital, Peking University, Shenzhen, Guangdong 518036, P.R. China.
Ji-Kui LiuDepartment of Hepatobiliary and Laparoscopic Surgery, Shenzhen Hospital, Peking University, Shenzhen, Guangdong 518036, P.R. China.
Li-Ping NieDepartment of Clinical Laboratory, Shenzhen Hospital, Peking University, Shenzhen, Guangdong 518036, P.R. China.
Yang ZhaoDepartment of Pathology, Shenzhen Hospital, Peking University, Shenzhen, Guangdong 518036, P.R. China.
Guang-Yin YuDepartment of Pathology, Shenzhen Hospital, Peking University, Shenzhen, Guangdong 518036, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the present study was to investigate the role of latency-associated peptide (LAP)

Indexed as

flow cytometryhepatocellular carcinomaimmunohistochemistryLAP+CD4+ T cellsperipheral blood mononuclear cellstumor microenvironment

Identifiers

PMID30116333
PMCPMC6090257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.